CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives tentative approval from the USFDA for Carbidopa and Levodopa Extended-Release Capsules30-03-2020
30-03-2020
Ipca and Cadila Healthcare gear up to make drug for coronavirus
Ipca is the biggest producer of the drug. Cadila Healthcare, based in Ahmedabad, too is a major player23-03-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
With reference to the captioned subject, please find enclosed disclosure in prescribed Form 'C' under Regulation 7[2] of SEBI [Prohibition of Insider Trading] Regulations, 2015, received from Mrs. Rupa Parekh, a relative of Mr. Nitin D. Parekh, Chief Financial Officer of the Company with respect to sale of 10,000 Equity Shares of Re. 1/- each in the open market.20-03-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to regulation 30 of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we hereby inform that the Company has planned Analyst and Investors' conference call on March 20, 2020 at 3:00 p.m., to explain the impact of COVID-19 on the business. Axis Capital Limited is the facilitator for this call. The Call details are attached herewith.20-03-2020
Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Prakash Gaba for short term
Sudarshan Sukhani of s2analytics.com suggests buying ACC with stop loss at Rs 1090 and target of Rs 1160 and Cadila Healthcare with stop loss at Rs 255 and target of Rs 272.18-03-2020
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Record Date for Interim Dividend for the financial year 2019-202017-03-2020
Coronavirus pandemic: Here are the Indian companies developing the vaccine
Serum Institute of India, Zydus Cadila and Bharat Biotech are working towards developing vaccines against COVID-19.16-03-2020
CADILA HEALTHCARE LTD. - 532321 - Record Date For Interim Dividend
Record Date for Interim Dividend16-03-2020
CADILA HEALTHCARE LTD. - 532321 - Interim Dividend
Interim Dividend for the financial year 2019-202016-03-2020
Cadila board okays transfer of animal healthcare business to subsidiary
Drug firm Cadila Healthcare on Wednesday said its board has approved the transfer of its animal healthcare business to its wholly-owned arm Zydus A11-03-2020